Skip to main content
. 2014 Sep 19;9:1581–1593. doi: 10.2147/CIA.S65475

Table 3.

Summary of final ADR risk-prediction models

Author Significant variables in multivariate analysis Variable coefficient OR (CI) Attributed score Validation
McElnay et al12 Prescribed antidepressants 1.7569 5.7942 (2.12–15.85) None Internal (204 patients)
Prescribed digoxin 0.6884 1.9905 (1.05–2.33) Accuracy 63.0%
Gastrointestinal problems 0.7704 2.1606 (1.13–4.15) Sensitivity 40.5%
Abnormal potassium level 0.9455 2.5740 (1.35–4.91) Specificity 69.0%
Thinks drugs were responsible 1.4375 4.2103 (2.18–8.14)
−1.7861 0.1676 (0.07–0.42)
Experiences angina 0.8779 2.4057 (1.06–5.44)
Experiences COAD −1.0997 (constant)
Tangiisuran13 Hyperlipidemia 1.199 3.316 (1.811–6.072) 1 External (483 patients)
Number of medications ≥8 1.194 3.300 (1.927–5.651) 1 Sensitivity 80.0%
Length of stay ≥12 days 0.819 2.269 (1.345–3.826) 1 Specificity 55.0%
Use of hypoglycemic agents 0.645 1.906 (1.040–3.493) 1 AUROC 0.73 (95% CI 0.66–0.80)
0.437 1.548 (0.940–2.548) 1
High white blood cell count on admission −3.628 (constant)
Onder et al14 (O’Connor et al)22 ≥4 comorbidities Not reported 1.31 (1.04–1.64) 1 External (483 patients)
Heart failure 1.79 (1.39–2.30) 1 Sensitivity 68%
Liver disease 1.36 (1.06–1.74) 1 Specificity 65%
Number of drugs ≤5 1 Reference AUROC 0.70 (95% CI 0.63–0.78)
Number of drugs 5–7 1.9 (1.35–2.68) 1 External (513 patients)
Number of drugs ≥8 4.07 (2.93–5.65) 4 AUROC 0.623 (95% CI 0.570–0.676)
Previous ADR 2.41 (1.79–3.23) 2
Renal failure 1.21 (0.96–1.51) 1
Trivalle et al15 Number of medications Not reported 1.9 (1.6–2.3) Internal (bootstrap)
0–6 2.5 (1.5–4.1) 0 AUROC 0.70 (95% CI 0.65–0.74)
7–9 2.0 (1.1–1.37) 6
10–12 12
≥13 18
Antipsychotic treatment 9
Recent anticoagulant 7

Abbreviations: ADR, adverse drug reaction; AUROC, area under the receiver operator curve; CI, confidence interval; COAD, chronic obstructive airways disease; OR, odds ratio.